Efficacy and Tolerability of a New Non-Extrafine Formulation of Beclomethasone HFA-134a in Patients with Asthma: Comparison with Beclomethasone CFC

By Rocca-Serra J.P.  

Clinical Drug Investigation, Vol. 22, Iss. 10, 2002-01 ,pp. : 653-665

Adis International

Access to resources Recommend Favorite

Formulation of a protein with propellant HFA 134a for aerosol delivery

By Williams III R.O.   Liu J.  

European Journal of Pharmaceutical Sciences, Vol. 7, Iss. 2, 1999-01 ,pp. : 137-144

Elsevier

Access to resources Recommend Favorite

A Comparison of Fluticasone Propionate, 100µg Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma

By Stone D.W.G.  

Clinical Drug Investigation, Vol. 21, Iss. 10, 2001-10 ,pp. : 695-703

Adis International

Access to resources Recommend Favorite

One-Year Evaluation of the Safety and Efficacy of Ipratropium Bromide HFA and CFC Inhalation Aerosols in Patients with Chronic Obstructive Pulmonary Disease

By Brazinsky S.A.  

Clinical Drug Investigation, Vol. 23, Iss. 3, 2003-01 ,pp. : 181-191

Adis International

Access to resources Recommend Favorite

Influence of formulation technique for hydroxypropyl- -cyclodextrin on the stability of aspirin in HFA 134a

By Williams III R.O.   Liu J.  

European Journal of Pharmaceutics and Biopharmaceutics, Vol. 47, Iss. 2, 1999-03 ,pp. : 145-152

Elsevier

Access to resources Recommend Favorite